Target intelligence / Profile preview

Tissue repair via paracrine signaling

Molecular classification
Other (cell-cell communication mechanism), Growth factor family, Cytokine family, Chemokine family
01

Overview

Tissue repair via paracrine signaling refers to the biological phenomenon where certain cells—most notably mesenchymal stem/stromal cells—secrete soluble mediators such as growth factors (FGFs, VEGFs), cytokines (ILs), chemokines and extracellular vesicles into their immediate environment. These mediators act locally on neighboring damaged tissues by binding specific surface receptors on recipient cells. This triggers intracellular cascades promoting processes like angiogenesis, reduced inflammation, increased cellular survival/proliferation/migration and ultimately enhanced tissue regeneration. Importantly, these effects occur even when donor/therapeutic cells do not engraft long-term within the repaired tissues; instead their transient presence suffices due to robust activation of endogenous reparative programs through these secreted signals. This concept underpins much current research into “cell-free” regenerative therapies using conditioned media or purified exosomes from therapeutic cell types. However—as it does not denote any one molecular entity—it should not be treated as an individual druggable target.

Other names
Paracrine-mediated tissue repairParacrine effect in regenerationParacrine wound healing
02

Mechanism of action

Secretion of growth factors/cytokines/chemokines that bind receptors on local cells and activate downstream regenerative pathways. Promotion of angiogenesis, reduction of inflammation, stimulation of resident progenitor/stem cell activity.

03

Biological functions

Tissue regenerationWound healingAngiogenesisCell proliferationInflammation modulation
04

Disease associations

Cardiovascular disease (myocardial infarction recovery)Ischemic injuryChronic woundsOther diseases involving impaired tissue regeneration
05

Safety considerations

Uncontrolled cell proliferation leading to fibrosis or tumorigenesis if signals are dysregulatedImmune reactions if allogeneic donor cells are usedOff-target effects due to pleiotropic nature of secreted factors
06

Interacting drugs

Growth factor therapies (recombinant FGF, VEGF)

1 more in the full profile.

07

Biomarkers

Levels of secreted growth factors/cytokines such as VEGF, FGF2Markers for angiogenesis or cellular proliferation

Beyond the preview

Go deeper on Tissue repair via paracrine signaling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue repair via paracrine signaling.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call